Literature DB >> 10582740

Management of hypertension controls postoperative neurologic disorders after renal transplantation in cats.

A E Kyles1, C R Gregory, J D Wooldridge, K G Mathews, L R Aronson, L Bernsteen, J E Ilkiw.   

Abstract

OBJECTIVES: To determine the prevalence and describe the management of hypertension and central nervous system (CNS) complications after renal transplantation in cats. We also compared the prevalence of CNS complications between cats monitored and treated for postoperative hypertension and a previously described, historical control group of cats not monitored or treated for postoperative hypertension. STUDY
DESIGN: Retrospective clinical study. ANIMALS OR SAMPLE POPULATION: A total of 34 client-owned cats that received renal allografts for the treatment of end-stage renal failure.
METHODS: Medical records were reviewed. Data obtained included preoperative and postoperative systolic blood pressures, antihypertensive therapy, response to treatment, neurologic signs, and clinical outcome. The results were compared with a historical control group of feline renal allograft recipients that were neither monitored nor treated for postoperative hypertension.
RESULTS: Severe postoperative hypertension occurred in 21 of 34 of cats. Hypertension was treated in all 21 cats with subcutaneously administered hydralazine which reduced systolic blood pressure to less than 170 mm Hg in 15 minutes in 20 of 21 cats; hydralazine produced hypotension in one cat and failed to control hypertension in 1 cat. After transplantation, seizures were observed in one cat and other neurologic complications (stupor, ataxia, and central blindness) were observed in three cats. The prevalence of seizures and neurologic complication-related deaths after transplantation was significantly reduced with treatment of postoperative hypertension. CONCLUSIONS AND CLINICAL RELEVANCE: Hypertension is a major contributing factor to postoperative seizure activity after renal transplantation in cats; treatment of hypertension reduces the frequency of neurologic complications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10582740     DOI: 10.1111/j.1532-950x.1999.00436.x

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  6 in total

1.  Magnetic resonance imaging appearance of hypertensive encephalopathy in a dog.

Authors:  Chloe A Bowman; Adrian Witham; Dayle Tyrrell; Sam N Long
Journal:  Ir Vet J       Date:  2015-04-24       Impact factor: 2.146

2.  Survival after diagnosis of hypertension in cats attending primary care practice in the United Kingdom.

Authors:  Megan Conroy; Yu-Mei Chang; Dave Brodbelt; Jonathan Elliott
Journal:  J Vet Intern Med       Date:  2018-10-13       Impact factor: 3.333

3.  Comparison of Doppler ultrasonic and oscillometric devices (with or without proprietary optimisations) for non-invasive blood pressure measurement in conscious cats.

Authors:  Petra Cerna; Panos E Archontakis; Hester Ok Cheuk; Danièlle A Gunn-Moore
Journal:  J Feline Med Surg       Date:  2020-06-25       Impact factor: 2.015

4.  ACVIM consensus statement on pancreatitis in cats.

Authors:  Marnin A Forman; Joerg M Steiner; P Jane Armstrong; Melinda S Camus; Lorrie Gaschen; Steve L Hill; Caroline S Mansfield; Katja Steiger
Journal:  J Vet Intern Med       Date:  2021-02-15       Impact factor: 3.333

5.  ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats.

Authors:  Mark J Acierno; Scott Brown; Amanda E Coleman; Rosanne E Jepson; Mark Papich; Rebecca L Stepien; Harriet M Syme
Journal:  J Vet Intern Med       Date:  2018-10-24       Impact factor: 3.333

Review 6.  The cat with neurological manifestations of systemic disease. Key conditions impacting on the CNS.

Authors:  Marc Kent
Journal:  J Feline Med Surg       Date:  2009-05       Impact factor: 2.015

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.